MNPR
Monopar TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
MNPR vs peer average
76/100
MNPR vs. peer average (B vs. D)
Grade spread
A 1 · C 3 · D 4 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ACRS is the first available peer comparator.
Same-sector, similar-market-cap candidate, but direct indication and program comparability to MNPR are not established; loose comp only.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MNPR
Monopar Therapeutics
ACRS
Aclaris Therapeutics
Grade
B
D
Momentum
88
76
Value
41
41
Sentiment
68
40
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs ACRS
MNPR / ACRS
Grade Position
Above peers
MNPR vs. peer average (B vs. D)
76/100
Momentum
88
MNPRValue
41
MNPRSentiment
68
MNPRRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MNPR
ACRS is the first peer returned for this comparison set.